Johns Hopkins ABX Guide
Delafloxacin
INDICATIONS
FDA
FDA
- Acute bacterial skin and skin-structure infections (ABSSSI) caused by designated susceptible bacteria.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: April 5, 2019
Citation
Avdic, Edina. "Delafloxacin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540685/all/Delafloxacin.
Avdic E. Delafloxacin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540685/all/Delafloxacin. Accessed July 21, 2025.
Avdic, E. (2019). Delafloxacin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540685/all/Delafloxacin
Avdic E. Delafloxacin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2025 July 21]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540685/all/Delafloxacin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Delafloxacin
ID - 540685
A1 - Avdic,Edina,Pharm.D.
Y1 - 2019/04/05/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540685/all/Delafloxacin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
